Dr Reddys Laboratories (RDY) Share-based Compensation (2024 - 2025)

Dr Reddys Laboratories (RDY) recorded quarterly Share-based Compensation of $1.1 million in Q3 2025, down 12.4% quarter-over-quarter from $1.3 million in Q2 2025, and down 10.26% on a YoY basis from $1.3 million in Q3 2024.

Dr Reddys Laboratories (RDY) Share-based Compensation (2024 - 2025) Analysis & Trends

Dr Reddys Laboratories' Share-based Compensation history runs 2 years deep, the most recent figure standing at $1.1 million for Q3 2025.

  • In Q3 2025, Share-based Compensation fell 10.26% year-over-year to $1.1 million; the TTM figure through Sep 2025 stood at $4.9 million (changed N/A YoY), while the FY2026 annual figure was $3.0 million, down 40.0% from the prior year.
  • Share-based Compensation was $1.1 million for Q3 2025 at Dr Reddys Laboratories, down from $1.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.3 million in Q2 2025 to a low of $1.1 million in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 43.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 25.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 33.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -395,114.54
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 57.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 21.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 36.33 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 36.86 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 16.04 Mn
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 1.15 Mn
Sep 30, 2025 1.15 Mn
Jun 30, 2025 1.31 Mn
Jun 30, 2025 1.31 Mn
Sep 30, 2024 1.28 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 1.21 Mn
Jun 30, 2024 1.21 Mn